نتایج جستجو برای: gemistocytic glioblastomas

تعداد نتایج: 2385  

2013
Aditya Grover Anjali Hirani Vijaykumar Sutariya

Presenting a very dismal prognosis, glioblastomas present as one of the most malignant brain tumors [1]. In addition to its low prognosis, glioblastomas account for ~70% of all astrocytic and oligodendroglial tumors, making this one of the most common types of brain tumors [1]. Through the mutations of multiple pro-oncogenic genes, primary glioblastomas develop as other neoplasms but present as...

2009
Sumihito Nobusawa Takuya Watanabe Paul Kleihues Hiroko Ohgaki

Purpose: To establish the frequency of IDH1mutations in glioblastomas at a population level, and to assess whether they allow reliable discrimination between primary (de novo) glioblastomas and secondary glioblastomas that progressed from low-grade or anaplastic astrocytoma. Experimental Design: We screened glioblastomas from a population-based study for IDH1 mutations and correlated them with ...

Journal: :Neuro-oncology 1999
P Kleihues H Ohgaki

Glioblastomas may develop de novo (primary glioblastomas) or through progression from low-grade or anaplastic astrocytomas, (secondary glioblastomas). These subtypes of glioblastoma constitute distinct disease entities that evolve through different genetic pathways, affect patients at different ages, and are likely to differ in prognosis and response to therapy. Primary glioblastomas develop in...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2013
Christian Hartmann Bettina Hentschel Matthias Simon Manfred Westphal Gabriele Schackert Jörg C Tonn Markus Loeffler Guido Reifenberger Torsten Pietsch Andreas von Deimling Michael Weller

PURPOSE The determinants of long-term survival in glioblastoma have remained largely obscure. Isocitrate dehydrogenase (IDH) 1 or 2 mutations are common in World Health Organization (WHO) grades II and III gliomas, but rare in primary glioblastomas, and associated with longer survival. EXPERIMENTAL DESIGN We compared clinical and molecular characteristics of 69 patients with centrally confirm...

2014
Gentian Kaloshi Arben Roji Arsen Seferi Bujar Cakani Teona Bushati Ermir Roci Mentor Petrela

Spinal metastasis, a devastating neurologic complication of intracranial glioblastomas is not as uncommon as initially thought. It varies from 25% in supratentorial glioblastomas to 60% in infratentorial glioblastomas. The underlying pathogenesis spinal spread of high-grade gliomas is still unclear. To date, no causal responsibility of Bevacizumab (BEV) was noted. Here, we report for the first ...

2015
So Mee Kwon Shin-Hyuk Kang Chul-Kee Park Shin Jung Eun Sung Park Ju-Seog Lee Se-Hyuk Kim Hyun Goo Woo Javier S Castresana

Previously, transcriptomic profiling studies have shown distinct molecular subtypes of glioblastomas. It has also been suggested that the recurrence of glioblastomas could be achieved by transcriptomic reprograming of tumors, however, their characteristics are not yet fully understood. Here, to gain the mechanistic insights on the molecular phenotypes of recurrent glioblastomas, gene expression...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2017
Jörg Felsberg Bettina Hentschel Kerstin Kaulich Dorothee Gramatzki Angela Zacher Bastian Malzkorn Marcel Kamp Michael Sabel Matthias Simon Manfred Westphal Gabriele Schackert Jörg C Tonn Torsten Pietsch Andreas von Deimling Markus Loeffler Guido Reifenberger Michael Weller

Purpose: Approximately 40% of all glioblastomas have amplified the EGFR gene, and about half of these tumors express the EGFRvIII variant. The prognostic role of EGFRvIII in EGFR-amplified glioblastoma patients and changes in EGFRvIII expression in recurrent versus primary glioblastomas remain controversial, but such data are highly relevant for EGFRvIII-targeted therapies.Experimental Design:E...

Journal: :Neuro-Oncology 2015

2016
Kenney R. Roodakker Tamador Elsir Per-Henrik D. Edqvist Daniel Hägerstrand Joseph Carlson Malgorzata Lysiak Roger Henriksson Fredrik Pontén Johan Rosell Peter Söderkvist Roger Stupp Elena Tchougounova Monica Nistér Annika Malmström Anja Smits

PROX1 is a transcription factor with an essential role in embryonic development and determination of cell fate. In addition, PROX1 has been ascribed suppressive as well as oncogenic roles in several human cancers, including brain tumors. In this study we explored the correlation between PROX1 expression and patient survival in high-grade astrocytomas. For this purpose, we analyzed protein expre...

Journal: :AJNR. American journal of neuroradiology 2014
S Wang S J Kim H Poptani J H Woo S Mohan R Jin M R Voluck D M O'Rourke R L Wolf E R Melhem S Kim

BACKGROUND AND PURPOSE Differentiation of glioblastomas and solitary brain metastases is an important clinical problem because the treatment strategy can differ significantly. The purpose of this study was to investigate the potential added value of DTI metrics in differentiating glioblastomas from brain metastases. MATERIALS AND METHODS One hundred twenty-eight patients with glioblastomas an...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید